Frontline primary tumor resection followed by systemic therapy in metastatic breast cancer patients may be non- inferior to systemic treatment alone: A retrospective study.

Abstract

Primary tumor resection in metastatic breast cancer (MBC) remains a palliative procedure. Its impact as an upfront option on survival is debatable. No data from our locality addressed this issue

Keywords


Volume 8, Issue 3
September 2020
Pages 43-48
  • Receive Date: 08 September 2020
  • Revise Date: 17 September 2020
  • Accept Date: 24 September 2020